Sign Up Today and Learn More About Cambridge Analytica Stock
Invest in or calculate the value of your shares in Cambridge Analytica or other pre-IPO companies through EquityZen's platform.
Cambridge Analytica Stock
Cambridge Analytica They understand that every customer, every cause, and every campaign is unique.
About Cambridge Analytica Stock
Industries
Software, Artificial Intelligence, Data and Analytics
Cambridge Analytica Press Mentions
Stay in the know about the latest news on Cambridge Analytica
Zoom Is Looking More And More Like Facebook Every Day
Forbes • Apr 07, 2020
13 Challenges Tech Execs Are Facing (And How They're Overcoming Them)
Forbes • Mar 27, 2020
Australia sues Facebook over Cambridge Analytica, fine could scale to $529BN
TechCrunch • Mar 09, 2020
Facebook’s latest ‘transparency’ tool doesn’t offer much — so we went digging
TechCrunch • Feb 25, 2020
The Case For Antitrust: The Realities Of Competing With Big Tech
Forbes • Feb 20, 2020
Cambridge Analytica Management
Leadership team at Cambridge Analytica
Data Scientist
Federica Nocera
Head of Product
Matt Oczkowski
Join now and verify your accreditation status to gain access to:
- Cambridge Analytica current valuation
- Cambridge Analytica stock price
- Available deals in Cambridge Analytica and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Cambridge Analytica Stock
How to invest in Cambridge Analytica stock?
Accredited investors can buy pre-IPO stock in companies like Cambridge Analytica through EquityZen funds. These investments are made available by existing Cambridge Analytica shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Cambridge Analytica stock?
Shareholders can sell their Cambridge Analytica stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
